Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.

Journal article

Holt F. et al, (2023), Int J Radiat Oncol Biol Phys, 117, 869 - 882

Ki67 and breast cancer mortality in women with invasive breast cancer.

Journal article

Probert J. et al, (2023), JNCI Cancer Spectr, 7

Risk of breast cancer death after a diagnosis of early invasive breast cancer.

Journal article

MacKenzie M. et al, (2023), BMJ, 381

Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study.

Journal article

Dave RV. et al, (2023), Breast cancer research and treatment, 199, 265 - 279

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

Journal article

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: None. and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) None., (2023), Lancet, 401, 1277 - 1292

Cytotoxic Chemotherapy for Pancreatic Adenocarcinoma in England 2010-2017: Survival Outcomes.

Journal article

Wang Z. et al, (2023), Clin Oncol (R Coll Radiol)

Load More